肿瘤细胞免疫原性的可塑性：它可以成为药物作用靶点吗？
Plasticity of tumor cell immunogenicity: is it druggable?
作者信息
Dranoff Glenn
机构信息
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
出版信息
J Immunother Cancer. 2025 Apr 23;13(4):e011859. doi: 10.1136/jitc-2025-011859.
Abstract
This short perspective presents, at a high level, some observations and speculations about cancer immunotherapy that derive from experiences at the Dana-Farber Cancer Institute and the Novartis Institutes of Biomedical Research.
摘要
这篇简短的观点文章从较高层面呈现了一些关于癌症免疫疗法的观察结果和推测，这些内容源自丹娜法伯癌症研究所和诺华生物医学研究所的经验。
Zotero 插件